Tenajora, Merina A.
HRN: 06-15-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/25/2023
09/25/2023
IV
4.5g
Drip For 2 Hours
CAP MR; PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes